GoodRx Earns Webby, Digital Health Awards

GoodRx was named a People’s Voice Award winner at the 29th annual Webby Awards. The Webbys are presented by the International Academy of Digital Arts and Sciences and recognize excellence across internet media.

GoodRx was also honored with seven awards at the Spring 2025 Digital Health Awards. Overseen by the Health Information Resource Center, the Digital Health Awards honor leading digital health resources developed for consumers and health professionals. 

These awards affirm our mission to promote meaningful conversations around health and wellness, and help our audience make the best healthcare decisions for themselves and their families. 

Video team takes home Webby Award

GoodRx was recognized with a 2025 Webby’s People’s Voice Award, which is voted on by the public. The winning video — How Does It Feel to Give Birth? 4 Women Share Their Experience — was honored in the category of Video & Film, Health & Wellness. 

This video gives voice to the deeply personal and often underrepresented stories of childbirth, as candidly told by four women. Through raw honesty and vulnerability, the video sheds light on the emotional, physical, and psychological journeys of giving birth, offering a space for empathy, understanding, and connection.

Editorial content wins 7 awards

GoodRx was honored with gold, silver, bronze, and merit awards across two categories at the Spring 2025 Digital Health Awards. Award entries are evaluated by type of content, format, targeted consumer audience, and overall quality.

Our story evaluating the evidence and risks of supplements to treat allergy symptoms received a gold award in the category of Digital Media/Publications, Single Article. GoodRx also earned two silver awards in the same category: 

• A GoodRx Savings Guide to 25 Asthma Inhalers 

• Are Your Probiotics Working? Look for These Signs

The story When Is Low Blood Pressure an Emergency? An ER Doctor Explains the Potential Dangers earned a bronze award.

In the category of Digital Media/Publications, Article Series, GoodRx took home a silver award for a collection of stories about GLP-1 weight loss medications. These articles were designed to help readers make informed decisions and track how scientific knowledge about these popular drugs continues to evolve: 

• From Diabetes to Alzheimer’s: Live Updates on Semaglutide’s Current and Future Uses

• From Diabetes to Heart Failure: Live Updates on Tirzepatide’s Current and Future Uses

• Can You Get Pregnant While Taking Ozempic? How Weight-Loss Medications Affect Fertility

• Here’s Why Weight Loss Can Stop While Taking Ozempic or Wegovy

• Does Semaglutide Make You Blind? Here’s How the Popular Weight-Loss Drug Can Affect Your Eyes

• Tirzepatide (Mounjaro, Zepbound) Is Off the Shortage List: Here’s What That Means for You

GoodRx also received a merit award for a second series about accessing and affording GLP-1 medications. The stories include a research report on weight loss medication fills and costs, and a series of service-driven articles meant to help readers determine whether their insurance will cover these medications and how to save money on any out-of-pocket costs:

• Fills for Weight-Loss Medications Like Wegovy and Mounjaro Rise Despite High Out-of-Pocket Costs

• Does Insurance Cover Weight-Loss Medications Such As Wegovy or Zepbound?

• Does Medicare Cover Wegovy, Zepbound, and Other Weight-Loss Medications?

• Does TRICARE Cover Wegovy, Zepbound, and Other Medications Taken for Weight Loss?

• Does Medicaid Cover Ozempic, Wegovy, and Other Medications Taken for Weight Loss?

• A GoodRx Savings Guide to GLP-1 Receptor Agonists: Ozempic, Wegovy, Trulicity, and More

Lastly, GoodRx won a bronze award for a series of articles explaining the changes to Medicare Part D in 2025. These changes can help enrollees pay less out of pocket, manage their portion of prescription costs, and better understand their plans:

• The Medicare Part D Donut Hole Disappears in 2025

• The Medicare Prescription Payment Plan Starts in 2025

• The Medicare Part D $2,000 Out-of-Pocket Limit Starts in 2025

GoodRx is honored to be selected for these prestigious recognitions. Today’s healthcare environment is increasingly complex, leaving many Americans overwhelmed and unable to access or afford care. Our mission is to educate and aid our audience through the healthcare decision-making process with editorial and video content that is accessible, accurate, and actionable.